Evaluation of the anti-melanogenic activity of nanostructured lipid carriers containing auraptene: A natural anti-oxidant agent

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 302

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_NAMJ-9-1_006

تاریخ نمایه سازی: 19 دی 1400

Abstract:

Objective(s): In this work, we loaded Auraptene (AUR) into nanostructured lipid carriers (NLCs) and performed an assessment on inhibitory activities of the obtained AUR-NLCs on melanogenesis. Materials and Methods: AUR-NLCs were prepared through a high shear homogenization and ultrasound method. Results: Entrapment efficiency and Particle size of the optimized formulation were ۱۰۳.۱±۴.۹ nm and ۸۹.۵۶±۳.۷۵. The TEM outcomes exhibited the spherical shape of our nanoparticles, while the DSC analysis revealed the lack of any drug-lipid incompatibility throughout the formulations. A prolonged drug-release was observed from AUR-NLCs when compared to the AUR-solution. According to results, this product can significantly attenuated the activity of cellular tyrosinase and ROS content with minimal cytotoxic effects in B۱۶F۱۰ cell line, which in contrast to AUR-solution. Moreover, the western blotting analysis was indicative of AUR-NLCs ability to inhibit melanogenesis through the suppression of MITF and act much more efficiently than AUR-solution.Conclusion: AUR-NLCs can offer merits as a natural anti-tyrosinase agent for the treatment of hyperpigmentory disorders.

Authors

Sara Daneshmand

Department of Pharmaceutics, School of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran

Reavan Yazdian-Robati

Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Mahmoud Reza Jaafari

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Jebraeel Movafagh

Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Bizhan Malaekeh-Nikouei

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Mehrdad Iranshahi

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Shiva Golmohammadzadeh

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Zahra Tayarani-Najaran

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Rigon RB, Fachinetti N, Severino P, Santana MH, Chorilli M. ...
  • Kim M-J, Kim SS, Park K-J, An HJ, Choi YH, ...
  • Daneshmand S, Jaafari MR, Movaffagh J, Malaekeh-Nikouei B, Iranshahi M, ...
  • Das S, Ng WK, Tan RB. Are nanostructured lipid carriers ...
  • Al-Amin M, Cao J, Naeem M, Banna H, Kim M-S, ...
  • Kamali H, Khodaverdi E, Hadizadeh F, Ghaziaskar S. Optimization of ...
  • Daneshvar M, Kamali H, Masoomi M, Ghaziaskar H. Supercritical carbon ...
  • Amiri N, Moradi A, Tabasi SAS, Movaffagh J. Modeling and ...
  • Pardeike J, Schwabe K, Müller RH. Influence of nanostructured lipid ...
  • Okonogi S, Riangjanapatee P. Physicochemical characterization of lycopene-loaded nanostructured lipid ...
  • Daneshmand S, Golmohammadzadeh S, Jaafari MR, Movaffagh J, Rezaee M, ...
  • Han S, Kwon S, Jeong Y, Yu E, Park S. ...
  • Yang S, Zhu J, Lu Y, Liang B, Yang C. ...
  • Araujo J, Gonzalez-Mira E, Egea M, Garcia M, Souto E. ...
  • Hashemi-Shahri SH, Golshan A, Mohajeri SA, Baharara J, Amini E, ...
  • Emami SA, Yazdian-Robati R, Sadeghi M, Baharara J, Amini E, ...
  • Qiao Z, Koizumi Y, Zhang M, Natsui M, Flores MJ, ...
  • Kamagaju L, Morandini R, Bizuru E, Nyetera P, Nduwayezu JB, ...
  • Hassani FV, Abnous K, Mehri S, Jafarian A, Birner-Gruenberger R, ...
  • Hassani FV, Mehri S, Abnous K, Birner-Gruenberger R, Hosseinzadeh H. ...
  • Zhang W, Li X, Ye T, Chen F, Sun X, ...
  • Bikkad ML, Nathani AH, Mandlik SK, Shrotriya SN, Ranpise NS. ...
  • Mosallaei N, Jaafari MR, Hanafi‐Bojd MY, Golmohammadzadeh S, Malaekeh‐Nikouei B. ...
  • Golmohammadzadeh S, Mortezania S, Jaafari MR. Improved photostability, reduced skin ...
  • Kumar S, Bhanjana G, Kumar A, Taneja K, Dilbaghi N, ...
  • Chang T-S. Natural melanogenesis inhibitors acting through the down-regulation of ...
  • Sarkar R, Arora P, Garg KV. Cosmeceuticals for hyperpigmentation: What ...
  • Teskač K, Kristl J. The evidence for solid lipid nanoparticles ...
  • Limsuwan T, Boonme P, Khongkow P, Amnuaikit T. Ethosomes of ...
  • Müller R, Petersen R, Hommoss A, Pardeike J. Nanostructured lipid ...
  • نمایش کامل مراجع